Status:

RECRUITING

Non Interventional German Leptomeningeal Disease Register

Lead Sponsor:

University Hospital Tuebingen

Conditions:

Meningeal Neoplasms

Leptomeningeal Disease

Eligibility:

All Genders

18+ years

Brief Summary

The planned multicenter register is intended to create a database in the form of a cancer register on the incidence and course of disease in Germany of leptomeningeal disease, the therapeutic measures...

Detailed Description

This register is multicenter project in Germany. All patients eligible for this register are informed in detail about the register verbally and in writing by the treating and documenting physicians. T...

Eligibility Criteria

Inclusion

  • Patients with leptomeningeal disease
  • Written consent of the patient or legal guardian.
  • Capacity to give consent or legal guardianship
  • Age ≥ 18 years

Exclusion

  • Lack of informed consent from the patient
  • Lack of capacity to consent on the part of the person concerned or lack of legal guardianship
  • Age \< 18 years

Key Trial Info

Start Date :

June 26 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2029

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06146010

Start Date

June 26 2024

End Date

December 1 2029

Last Update

April 4 2025

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Universitätsklinikum Bonn Klinik und Poliklinik für Neurologie

Bonn, Germany, 53127

2

Universitätsmedizin Mannheim Universitätsklinikum Mannheim GmbH Klinik für Neurologie

Mannheim, Germany, 68167

3

Klinikum rechts der Isar | Technische Universität München; Klinik für Radioonkologie und Strahlentherapie

München, Germany, 81675

4

Diakonie Klinikum GmbH • Jung-Stilling-KrankenhausAbteilung Neurochirurgie

Siegen, Germany, 57074